Feature Story

News

08-15Pharmaceutical Biotech Scientist Discovers New Molecule to Treat Chronic Pain
08-12Northeastern Researchers Play Key Role in DZero International Physics Research Collaboration
08-01Northeastern University Researchers Discover New DNA Binding Activity of E. coli Protein
07-23Nanophotonics Research by Northeastern University Physics Professor leads to Nanomanufactured Optical Lenses

Announcements

07-21Three Northeastern Professors Hosting Panel Discussion during Entrepreneurs’ Organization 2008 EO University in Boston
06-02Northeastern Researchers Co-chair International Symposium on Cancer Nanotechnology, June 4th, Boston, MA
03-31Northeastern's NSF Nanotechnology Center Sponsors NanoDays, an Alternative Energy Event
02-11Northeastern will Host Local Students for Public Science Day, Sponsored by the American Association for the Advancement of Science (AAAS)

Research at Northeastern

Help For Researchers

Northeastern Research Division

Faculty Login

Faculty Login »»

Focus

Biotechnology

biotech

Alexandros Makriyannis and a team of researchers have created a synthetic molecule that could be used to treat chronic pain in patients with diseases such as diabetes or shingles.

Nanotechnology

nanotech

Using nanomanufacturing processes, Prof. Sridhar and his team have developed an optical microlens with a step-like surface that can operate at infrared frequencies using negative index refraction.

Sensing & Imaging

sensing

NU receives a gift of $20 million from The Gordon Foundation

Urban Affairs & Public Policy

urban

"The relationship between gang activity and recent increases in youth violence demands that agencies utilize new research and evaluation tools"